India's Pharma Consulting Partner
Chemora Life Sciences delivers end-to-end consulting across regulatory affairs, clinical research, and drug development — helping Indian pharmaceutical companies compete and succeed globally.
What we do
From early-stage discovery to post-market surveillance, our multidisciplinary team provides the scientific depth and regulatory precision your pipeline demands — built for the Indian pharma ecosystem.
Strategic guidance for CDSCO dossiers, NDAs, BLAs, and global submissions. We navigate FDA, EMA, CDSCO, and other health authority requirements to keep your program on track.
End-to-end clinical trial management — protocol design, CRO selection, site management across India, biostatistics, and CSR authoring aligned with ICMR, GCP, and global standards.
Scientific support from target identification through IND-enabling studies — integrating India's robust generics expertise with novel molecule development and ADMET profiling.
GMP, GCP, and GLP quality systems for Indian manufacturers. Audit readiness, WHO-GMP inspection preparation, and 21 CFR Part 11 compliance for export-oriented units.
India focus
India is the pharmacy of the world — supplying 20% of global generic medicines. We help Indian companies navigate the regulatory complexity of domestic markets and international expansion.
About us
Chemora Life Sciences was founded by scientists and regulatory professionals with deep roots in India's pharmaceutical industry — built on genuine expertise, not just process management.
Contact us
Reach out directly — our team responds within one business day.
"The depth of scientific knowledge Chemora brings is unlike any consulting firm we've worked with. They understood CDSCO's expectations better than our own team."
— VP Regulatory Affairs, Leading Indian Generics Company
What to include in your message